MedTrace Logo

Repeatability and Reproducibility of Multiparametric MRI

NCT03743272 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2025-12-01

No results posted yet for this study

Summary

This study aims to prospectively assess the repeatability and reproducibility of iron-corrected T1 (cT1), T2\*, and hepatic proton density fat fraction (PDFF) quantification with multiparametric MRI using the LiverMultiScan™ (LMS, Perspectum Diagnostics, Oxford, UK) protocol across different field strengths, scanner manufacturers and models.

Conditions

  • Liver Diseases
  • Primary Biliary Cirrhosis
  • Non-Alcoholic Fatty Liver Disease
  • Non-Alcoholic Steatohepatitis
  • Cirrhosis
  • Hemochromatosis
  • Viral Hepatitis
  • Autoimmune Hepatitis
  • Primary Sclerosing Cholangitis

Interventions

DEVICE

LiverMultiScan

Up to 6 separate 5-10 minute abdominal MRI scans. Each scan requires a short breath hold.

Sponsors & Collaborators

  • Perspectum

    lead INDUSTRY

Principal Investigators

  • Rajarshi Banerjee, BM BCh MS DPhil · Perspectum Diagnostics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-03
Primary Completion
2024-06-30
Completion
2024-06-30
FDA Device
Yes

Countries

  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03743272 on ClinicalTrials.gov